News About: R&D
Battle gets fiercer over hair dye market
Four makers of hair dyes – Dongsung Pharm, Dong-A Pharm, Yuhan Corporation and Choong-wae Pharm - have waged fiercer campaigns to raise their market share as there is rising demand from the large marts and cosmetic st...
Treatment guidelines for hepatocellular carcinoma to be updated
The National Cancer Center has updated treatment guidelines for patients with hepatocellular carcinoma (HCC, also called hepatoma) as part of efforts to combat cancer, according to Dr. Park Jung-won.
The guidelines...
Allergan, Samil jointly sponsor launching symposia on GanfortAllergan Korea said it has jointly sponsored with Samil Pharm concerning Ganfort, a Lumigan/timolol combination product for the treatment of glaucoma.
The symposia were held ...
|
Chong Kun Dang’s Pregrel demonstrates comparable to PlavixThe safety and efficacy can be achieved for 300 patients exposing to a high risk of coronary artery disease or its similar disease with Chong Kun Dang’s Pregrel, the generic ver...
|
ERBITUX(Cetuximab) approved for treatment of KRAS wild type metastatic colorectal cancer
Merck Korea announced on October 8 that the Korea Food and Drug Administration has approved Erbitux (cetuximab), a first-in-class and highly active IgG1 monoclonal antibody targeting the epidermal growth factor recept...
Handok, Actelion enter into licensing agreementHandok Pharm and Actelion Pharmaceuticals Korea announced on October 7 that they have entered into a licensing agreement for Actelion’s clazosentan, an intravenous endothelin re...
|
Merck Korea files patent confirmation trial over Cozaar Plus
Merck Korea says it filed to the KIPO a trial to confirm the scope of patent right pertaining to Cozaar Plus against Yuhan, Hanmi, Samil, Hanlim, Chong Kun Dang, Dong-A and Yongjin.
The Cozaar Plus patent is to las...
R&D drug technology center to open in next February
The Korea Food and Drug Administration and the National Institute of Toxicological Research has unveiled a plan to set up a R&D drug technology center in February next year in a bid to facilitate an earlier commercial...
Dongwha conducts phase 2 study of novel antibacterial quinolone
Dongwha Pharm says it has conducted a local phase 2 study of the oral formulation of DW-224a, a fluoroquinolone antibiotic at seven university hospitals between October 1, 2008 and October 31, 2009.
DW-224a is a ne...
ZIC-HILIC available in detecting melamine in food
The chromatography column SeQuant ZIC-HILIC from Merck KGaA can be used for detecting melamine in food, according to Merck Korea.
The chromatography column SeQuant ZIC-HILIC from Merck KGaA can be used for detectin...
